AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04465630 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: OMNI® Surgical System
Description: Ab-interno transluminal viscoelastic delivery and trabeculotomy performed with the OMNI Surgical System
Study NCT03880760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: L. johnsonii MH-68, B. animalis subsp. lactis CP-9 and L. salivarius AP-32
Description: Taking 1 L. johnsonii MH-68, B. animalis subsp. lactis CP-9 and L. salivarius AP-32 mix probiotics capsule twice a day before meals for six months.
Study NCT03880760 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Taking 1 placebo capsule twice a day before meals for six months.
Study NCT02754466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subjective vs objective criteria in selective excavation
Description: Subjective vs Objective criteria (Polymer burs) to perform selective excavation of dentin caries in deep lesions
Study NCT02754466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glass-ionomer vs Bulk fill composites in the ART approach
Description: High-viscosity glass-ionomer vs Bulk fill composite to restore shallow and medium depth dentin lesions using the ART approach
Study NCT03560349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine HCl Gel 2%
Description: Patients will be prescribed a regimen of 1 g acetaminophen q 8hrs alternating with 600 mg ibuprofen q 6 hours. In addition they will be instructed to continue oral fluid hydration and minimal activity for 24 hours.~At 2-hours following the SPG blockade an EBP will be offered to patients. Patient will also be informed that they can request an EBP at any time. The SPG blockade will be performed twice daily in the hospital and twice daily at home, by the patient. The patient will also be informed, if that at anytime, they would like an EBP, it can be provided.~While the study is being conducted, patients will not be offered a SPG block unless enrolled in the study.
Study NCT03560349 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo gel
Description: Patients will be prescribed a regimen of 1 g acetaminophen q 8hrs alternating with 600 mg ibuprofen q 6 hours. In addition they will be instructed to continue oral fluid hydration and minimal activity for 24 hours.~At 2-hours following the SPG blockade an EBP will be offered to patients. Patient will also be informed that they can request an EBP at any time. The SPG blockade will be performed twice daily in the hospital and twice daily at home, by the patient. The patient will also be informed, if that at anytime, they would like an EBP, it can be provided.~While the study is being conducted, patients will not be offered a SPG block unless enrolled in the study.
Study NCT03052322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MSB11022
Description: Participants received MSB11022 (modified buffer and stabilizer) subcutaneously at dose of 40 milligram (mg) every other week from Day 1 up to Week 48.
Study NCT03052322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EU-Humira
Description: Participants received EU-Humira subcutaneously at dose of 40 mg every other week from Day 1 up to Week 48.
Study NCT04331444 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CGM
Description: Using the CGM during the entire study period of 12 months.
Study NCT04024826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LFP
Description: This group will perform the Resistance training intervention on day 11 of the menstrual cycle, which corresponds to the mid of late follicular phase.
Study NCT04331444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: training course
Description: The participants in the three groups will attend a three-hour training course with different content depending on the group allocation. The aim of this training course is to ensure that the participants have the knowledge, support and confidence to work collaboratively with their HCPs to increase TIR and decrease HbA1c.
Study NCT04331444 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: training course
Description: The participants in the three groups will attend a three-hour training course with different content depending on the group allocation. The aim of this training course is to ensure that the participants have the knowledge, support and confidence to work collaboratively with their HCPs to increase TIR and decrease HbA1c.
Study NCT04331444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-support
Description: The peer-support will be facilitator-led by the primary investigator with peer exchange in group sessions (3 sessions over the study period, 3 hours per session) with 6-8 participants in every group.
Study NCT01948986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Description: Single oral administration of 3 X 5 mg tablets.
Study NCT03479463 — intervention group
Intervention type: BIOLOGICAL
Intervention: Dehydrated human amnion/chorion membrane
Description: Laryngectomy/pharyngectomy patched with dehydrated human amnion chorion allograft
Study NCT01519986 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Description: Supplement of vitamin D3
Study NCT01519986 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT03893474 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: OCT
Description: Optical Coherence Tomography of study eye.
Study NCT03893474 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Visual Acuity
Description: Visual acuity measured by ETDRS
Study NCT03996161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: patient position
Description: After the induction of anesthesia, mask ventilation is performed in the supine and semi-sitting position in a cross-over, randomized order.
Study NCT03996161 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: patient position
Description: After the induction of anesthesia, mask ventilation is performed in the supine and semi-sitting position in a cross-over, randomized order.
Study NCT02038465 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for patient
Study NCT02038465 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for healthy volunteers
Study NCT02483143 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NAC
Description: 3 gr NAC was made up to 1000 ml with NS; a 1 ml/3 mgr NAC solution was obtained and 3 ml/kg NAC+NS solution was administered for 1 h before CTPA and a 1 ml/kg per hour NAC+NS solution was administered for a minimum 6 h after CTPA.
Study NCT02483143 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NaHCO3
Description: 132 mEq NaHCO3 was made up to 1000 ml with NS; and 3 ml/kg NaHCO3+NS solution was administered for 1 h before CTPA and 1 ml/kg per hour NaHCO3+NS solution was administered for a minimum of 6 h after CTPA.
Study NCT04024826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ELP
Description: This group will perform the Resistance training intervention on the day 18 of the menstrual cycle, which corresponds to the mid of early luteal phase
Study NCT04024826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LLP
Description: This group will perform the Resistance training intervention on day 21 of the menstrual cycle, which corresponds to the mid of late luteal phase
Study NCT02148588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral nerve block with 2% lidocaine
Description: Patients will have a peripheral nerve blockade with a local anesthetic (lidocaine)~Assessment of spontaneous and evoked pain responses~Completion of NPSI questionnaire~Mapping of the affected limb
Study NCT02483702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Irradiated Blood Transfusions
Description: Same as arm description - need to collect extracellular potassium values.
Study NCT02483702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Irradiated Blood Transfusions
Description: Same as arm description - need to collect extracellular potassium values.
Study NCT02061579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured Group Exercise
Description: The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting. Group sessions include Aerobic Training and Combined Training. Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week. Participants in both groups will attend three exercise evaluations during the intervention period. Participants will also use provided logs to track their daily exercise activities outside of group sessions. Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.
Study NCT04070118 — intervention group
Intervention type: PROCEDURE
Intervention: Measure niche thickness with ultrasound
Description: in patients with previous cesarean section who applied to the emergency department with pain and underwent surgery; Measure niche thickness before operation
Study NCT00810459 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trilogy Ventilator
Description: Exposure to one hour on the Trilog ventilator
Study NCT00810459 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Exposure of one hour on the Participants prescribed ventilator
Study NCT02853032 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active repetitive transcranial magnetic stimulation
Description: The MagPro R30 is an advanced, high performance magnetic stimulator designed primarily for non-invasive clinical use. The non-invasive brain stimulation system will be used to deliver active repetitive electromagnetic pulses in this research study's treatment of post-traumatic stress disorder.
Study NCT02853032 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: robotic arm
Description: This robotic system is based on a commercially available neurosurgical robot. The robot is mounted on a mobile (i.e. retractable wheels) cart which holds the robot controller and the TMS power supply and pulse-generation computer. The robotic system will be used for TMS coil positioning/targeting.
Study NCT02853032 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: robotic arm
Description: This robotic system is based on a commercially available neurosurgical robot. The robot is mounted on a mobile (i.e. retractable wheels) cart which holds the robot controller and the TMS power supply and pulse-generation computer. The robotic system will be used for TMS coil positioning/targeting.
Study NCT02853032 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation
Description: The MagPro R30 is an advanced, high performance magnetic stimulator designed primarily for non-invasive clinical use. The non-invasive brain stimulation system will be used to deliver placebo repetitive electromagnetic pulses in this research study's treatment of post-traumatic stress disorder.
Study NCT02483143 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 3 ml/kg NS was administered for 1 h before CTPA and 1 ml/kg per hour was administered for a minimum of 6 h after CTPA.
Study NCT00003093 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim
Study NCT00003093 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sargramostim
Study NCT00003093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Study NCT00003093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT00003093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride
Study NCT00003093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Study NCT00003093 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional surgery
Study NCT02014025 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open hepatectomy
Description: We let the 45 patients who are meet the inclusion criteria .Hospital in hepatobiliary surgery A and D district is Group A ,they will accept Open Hepatectomy: tumors are totally resected by conventional laparotomy.
Study NCT02014025 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscope hepatectomy
Description: We let the 45 patients who are meet the inclusion criteria .Hospital in hepatobiliary surgery E district is Group B ,they will accept Laparoscopic Hepatectomy: tumors are totally resected through laparoscopic.
Study NCT00003093 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: neoadjuvant therapy
Study NCT04941339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG002
Description: Administrated intravenously
Study NCT02633735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Appy CDS
Description: See description under arm/group section
Study NCT03048773 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: shockwave therapy
Description: Intervention with shockwave therapy
Study NCT03296852 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: SONAS Ultrasound Device
Description: To assess a baseline value, ultrasound will be transmitted following an automated protocol to increase subsequently the output voltage from 5 volts to 50 volts. At each voltage step the received signals will be acquired and stored. Once the maximum output voltage of 50 Volts has been reached an additional 10 ultrasound pulses will be transmitted and the received data acquired. The total duration of this first data acquisition is 20 seconds. Following the IV bolus injection of Lumason™, ultrasound will be transmitted and received signals acquired following the same protocol as before.
Study NCT03048773 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PT
Description: Physical therapy 3 times per week for 3 weeks
Study NCT03048773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PT
Description: Physical therapy 3 times per week for 3 weeks
Study NCT03048773 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: sham shockwave therapy
Study NCT03296852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumason
Description: An IV line will be placed in a cubital or forearm vein. A bolus of 1.0ml of the ultrasound contrast agent (so called 'Microbubbles') Lumason™, internationally known as SonoVue (Bracco Pharmaceuticals, Italy), will be injected into the IV line, followed by a 5.0ml IV bolus injection of saline. Lumason™ has been FDA approved for cardiac applications to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. In the context of the present study Lumason™ would be used off-label.
Study NCT00536848 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14
Study NCT00536848 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00536848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Study NCT00473109 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dialysis without systemic heparinization
Description: Dialysis without systemic heparinization
Study NCT03053934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online video-based counselling
Description: Videoconferencing facilitates communication between individuals (i.e., the counsellor and the client) in different geographical locations enabling them to interact simultaneously with each other on a computer monitor in real time. In other words, both the client and the therapist communicate live using both visual and audio aids simulating in-person therapy albeit from two separate geographical locations.
Study NCT03053934 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional in-person counselling
Description: Traditional in-person counselling is often referred to as face-to-face and can be loosely defined as any mental health intervention, whereby the clinician is in the same room with a client. The terms in-person and same room are used less frequently, but it has been argued that these terms are more descriptive (since in videoconferencing, clients are also seen face-to-face on screen). Therefore, the current study uses the term in-person to describe traditional, face-to-face counselling.
Study NCT02961244 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prewarming and perioperative warming with Forced Air Warming device and its blankets.
Study NCT03544658 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental prophylaxis
Description: Professional dental prophylaxis including dental scaling and dental polishing with prophylactic paste
Study NCT03544658 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment by the participant
Description: Tooth color assessment using the VITA Classical shade guide. Assessment will be done with normal light conditions and with a light correcting device
Study NCT00536848 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metronidazole
Study NCT02961244 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Forced Air Warming blanket
Study NCT02828007 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIV Group
Description: Each patient will be using Non Invasive Ventilation (NIV) and will use it on each possible ventilation mode in a random order with a 10 minutes washout period between modes.
Study NCT03287245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idasanutlin
Description: All participants will receive 150 milligrams (mg) idasanutlin orally, once daily for 5 days, every 28 days, until treatment discontinuation or end of study (up to 2 years). Intra-participant dose-escalation to 200 mg daily for 5 days may be permitted after Cycle 3 for those who demonstrate no hematocrit (Hct) control and/or for those with inadequately controlled leukocytosis and/or thrombocytosis in which the investigator judges that better control is important.
Study NCT03824392 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Efzofitimod 1.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 1.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks
Study NCT03683368 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: YpsoPump Orbit soft
Description: Insulin infusion sets will be used for up to 7 days or until failure
Study NCT03544658 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment by the investigator
Description: Tooth color assessment using the VITA Classical shade guide and the VITA Toothguide 3D Master. Assessment will be done with normal light conditions and with a light correcting device
Study NCT03544658 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment with SpectroShade
Description: Tooth color assessment using SpectroShade (dental spectrophotometer). Color will be registered in VITA Classical and VITA Toothguide 3D Master and CIELab parameters
Study NCT04158115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Entire Spine Mobilization
Description: 8 sessions of Following: -Entire Spinal Mobilization of all spinal segment from C0 to C1 to L5 to S1 (10 reps × 3 sets), - Moist heat: 10 to 15 minutes, - Soft tissue Mobilization, - Exercises : (Knee to chest, Bridging. Hamstrings Stretching, TA stretching)
Study NCT04158115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Segmental Mobilization
Description: 8 sessions of following -Segmental Mobilization: All lumbar segment from L1 to L2 to L5 to S1 (10 reps × 3 sets) - Moist heat: (10 to 15 minutes), -Soft tissue Mobilization~- Exercises: (Knee to chest, Bridging. Hamstrings Stretching, TA stretching)
Study NCT04199910 — intervention group
Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V419
Description: V419 (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate \[Meningococcal Outer Membrane Protein Complex\], and Hepatitis B \[Recombinant\] Vaccine) 0.5 mL intramuscular injection at 2, 4, and 6 months of age
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DAPTACEL™
Description: DAPTACEL™ 0.5 mL intramuscular injection at 15 months of age
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DAPTACEL™
Description: DAPTACEL™ 0.5 mL intramuscular injection at 15 months of age
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PedvaxHIB™
Description: PedvaxHIB™ 0.5 mL intramuscular injection at 15 months of age
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar 13™
Description: Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age
Study NCT01337167 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Prevnar 13™
Description: Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age